Rapid Strep A Test Kit (Throat Swab Dipstick)

A Rapid Strep A test kit for throat swabs is a point-of-care diagnostic kit used to quickly detect Group A Streptococcus (Strep A) bacteria – the cause of “strep throat” – in a patient’s throat specimen. These kits use a lateral-flow (immunochromatographic) dipstick or cassette device coated with antibodies that bind Streptococcus group A antigen. In practice, a sterile swab is rubbed on the patient’s tonsils/pharynx and then mixed with an extraction buffer. The dipstick (or test cassette) is inserted into the sample mixture, and within about 5 minutes a colored line appears if Strep A antigen is present. A second “control” line should always appear to confirm the test ran correctly. For example, Quidel’s QuickVue® Dipstick Strep A test “detects group A Streptococcal antigen directly from patient throat swab specimens” and is used as “an aid in the diagnosis of group A Streptococcal infection”. Similarly, other manufacturers describe their Strep A rapid kits as “rapid chromatographic immunoassays” for qualitatively detecting Strep A antigen from throat swabs.

The Rapid Strep A Testing Kit Throat Swab Specimen Dipsticks are utilised for the quick diagnosis of strep throat, caused by the Streptococcus pyogenes bacterium. This essential point-of-care test enables healthcare providers to swiftly determine the presence of a bacterial infection, differentiating it from viral infections. It involves using a throat swab to collect a sample, and the dipsticks deliver accurate results in minutes. Prompt diagnosis allows for timely antibiotic treatment, reducing the risk of complications and limiting the spread of the infection.

How the Test Works

The core of the kit is a nitrocellulose test strip (dipstick) with two key antibody regions. One region (the test line) is coated with anti–Strep A antibodies; the other is a control line with antibodies that bind a built‐in control. When the swab sample (mixed in buffer) is applied, any Strep A antigens in the sample bind colloidal gold (or colored) particles conjugated to antibodies. Capillary action pulls the mixture along the strip. If Group A strep antigen is present, it will be captured at the test line and form a visible colored band. A colored control line will always form downstream to indicate the test strip is working properly. In short, two visible lines = positive (Strep A detected); one line (control only) = negative. These devices are purely qualitative – they indicate presence or absence of antigen, not amount.

The test reagents (swabs, buffers, dipsticks) are usually supplied in a self-contained kit. A typical kit (often sold in boxes of 20–25 tests) includes sterile throat swabs, pre-measured buffer tubes (extraction solution), and individually sealed dipstick cassettes or strips. For example, one commercial kit contains 20 individually wrapped test cassettes, 20 dropper bottles of extraction buffer (commonly a nitrite/acetic acid solution), and 20 sterile swabs. The testing process is straightforward:

• Collect sample: Using the provided sterile swab, rub the back of the patient’s throat/tonsils (avoiding the tongue) to collect mucous and epithelial cells.
• Extract antigen: Place the swab into the extraction tube containing buffer. Some kits use a one- or two-step chemical buffer (e.g. sodium nitrite and acetic acid) to break open cells and release antigen. Shake or swirl the swab in the solution for about 2–5 minutes so the antigen diffuses into the liquid.
• Apply to test: Remove the swab, squeezing it against the tube wall to recover liquid. Then either dip the test strip (dipstick) into the tube or add a dropperful of the liquid into the sample well of the test cassette.
• Wait and read: Allow the strip to develop for the specified time (commonly 5 minutes). A colored control band should appear to show the test is valid. If Group A strep antigen was present, a second line will appear at the test region. Interpretation: Two lines = positive for Strep A (test and control); one line = negative (control only).

Each step is usually illustrated in the kit manual. The entire process takes only a few minutes, so results are available long before a culture would grow.

Accuracy and Clinical Use

Rapid Strep A kits are highly specific but moderately sensitive compared to throat culture (the traditional gold standard). Most published evaluations and product inserts report sensitivities typically in the 85–95% range and specificities ~95–100%. For instance, Quidel’s QuickVue test cites ~92% sensitivity and 98% specificity; CITest’s cassette lists 95.0% sensitivity and 97.8% specificity. This means false positive results (specificity shortfall) are rare, but false negatives can occur if antigen levels are low. In practice, a positive rapid test is very reliable evidence of Group A strep infection, while a negative test does not completely rule it out.

Because of this, clinical guidelines recommend confirming negative rapid tests in certain cases. The CDC advises that in children with symptoms of strep throat, a negative rapid antigen test should be followed up by a standard throat culture. (Adults with a negative rapid test are often not cultured, as strep is less common and complications are rarer.) In short, the rapid test is fast (results in ~5 minutes) and aids prompt diagnosis and treatment, but a clinician may still confirm negatives by culture when needed.

Kit Contents:

• 25 Dipsticks: Individually sealed dipsticks designed for the detection of Streptococcus A antigen, ensuring optimal sterility and accuracy.
• 25 Disposable Extraction Test Tubes: Facilitates efficient processing of the swab specimens with minimised risk of contamination.
• 25 Sterile Swabs: High-quality swabs for effective and comfortable throat specimen collection.
• Reagent 1 (10 mL; 2M Sodium Nitrite): A potent chemical solution used to react with the sample for strep detection.
• Reagent 2 (10 mL; 0.2M Acetic Acid): Complements Reagent 1 to complete the chemical reaction required for accurate test results.
• Positive Control (1 mL; Non-viable Strep A; 0.09% NaN3): Enables performance verification of the dipsticks to ensure consistent test reliability.
• Negative Control (1 mL; Non-viable Strep C; 0.09% NaN3): Confirms the specificity of the testing process by ensuring no cross-reactivity.
• Instructional Insert: Provides a detailed guide to conducting the test, ensuring clarity and ease of use for healthcare personnel.
• Workstations: Compact, functional workstations to facilitate an organised and efficient testing process.

Engineered for practicality and reliability, the kit follows a straightforward testing protocol, requiring minimal preparation while maximising diagnostic accuracy. Each component of the kit is precisely manufactured to maintain test integrity, from specimen collection to result interpretation. The compact, user-friendly design makes it an ideal choice for diagnostic scenarios where time and accuracy are critical.

Key Features:

• Rapid Diagnostics: Delivers results expediently, enabling timely treatment and improved patient outcomes.
• User-Friendly Process: Simplified testing protocol that requires minimal training, ideal for high-volume settings.
• High Accuracy: Utilises advanced chemical reagents for precise and dependable detection of Group A Streptococcus.
• Comprehensive Kit: Includes all necessary components, ensuring an all-in-one solution for strep testing. Easy Storage: Compact kit design suited for efficient storage and transport, fitting effortlessly into any clinical environment.

A Rapid Strep A throat swab kit is an immunochromatographic “dipstick” test that detects Group A streptococcal antigen in a pharyngeal swab. It works by binding Strep A antigen to antibodies on a test strip, producing visible lines in about 5 minutes. Positive tests reliably indicate strep infection; negative tests may require confirmation by culture in pediatric cases. These kits are widely used to quickly identify strep throat and guide treatment.

• Product: McKesson Infectious Disease Immunoassay Rapid Strep A Test Kit, 25 Dipstick Tests Per Box
• Test Method: Lateral flow immunoassay designed for the detection of Group A Streptococcus (Streptococcus pyogenes) antigen from throat swab specimens
• Result Time: Rapid results at point of care, specific turnaround time not specified in provided data; consult product insert
• Complete Kit: All components included dipsticks, extraction tubes, sterile swabs, Reagents 1 and 2, positive and negative controls, instructional insert, and workstations
• Quality Controls Included: Both positive control (non-viable Strep A) and negative control (non-viable Strep C) supplied for performance and specificity verification
• Use Case: Designed to support differential diagnosis of bacterial vs. viral pharyngitis at the point of care in clinical, urgent care, EMS, and institutional settings
• Pack Size: 25 tests per box — suited for routine clinical stocking and high-volume procurement

• Primary Application: Point-of-care rapid detection of Group A Streptococcus pyogenes antigen from throat swab specimens to support differential diagnosis of bacterial vs. viral pharyngitis
• Intended User Settings: Physicians' offices, urgent care clinics, hospital outpatient departments, EMS and emergency response units, school health clinics, and occupational health facilities
• Clinical Decision Support: Designed to enable timely antibiotic prescribing decisions at the point of care — reducing unnecessary antibiotic use in viral presentations and supporting prompt treatment of confirmed bacterial infection
• Paediatric Considerations: Per IDSA guidelines (Shulman et al., 2012), negative rapid strep results in children and adolescents with high clinical suspicion should be followed up with confirmatory throat culture, given higher strep prevalence and rheumatic fever risk in this population
• Adult Considerations: In adult patients with low clinical suspicion, a negative rapid strep test is generally considered sufficient to withhold antibiotic therapy without culture confirmation, per current IDSA guidance
• High-Volume Suitability: The simplified protocol and complete kit contents are designed to minimise preparation time, supporting efficient testing throughput in busy clinical environments

• For Professional Use: This step test kit is intended for use by qualified healthcare professionals trained in point-of-care diagnostic procedures — not for unsupervised lay consumer use
• Chemical Reagent Handling: Reagent 1 (2M Sodium Nitrite) and Reagent 2 (0.2M Acetic Acid) are chemical solutions; handle according to the instructional insert and applicable laboratory safety protocols — avoid contact with skin, eyes, and mucous membranes
• Sodium Azide (NaN3) in Controls: Both positive and negative controls contain 0.09% Sodium Azide as a preservative — do not dispose of via drain systems; follow local hazardous waste disposal regulations
• Single-Use Components: All dipsticks, extraction tubes, and swabs are single-use only — do not reuse any component; reuse may compromise result integrity and introduce cross-contamination risk
• Result Interpretation Limitations: Sensitivity of rapid strep immunoassays is reported in the range of 70–90% (Choby, 2009) — a negative result does not absolutely exclude Strep A infection; clinical judgment and, where indicated, confirmatory culture should guide treatment decisions
• Material Safety: Sterility, latex content, and additional material safety properties are not specified in the provided data — refer to the product insert and McKesson product documentation for full material safety information
• Regulatory Status: FDA clearance number and CLIA waiver status are not specified in the provided data — confirm compliance status with Mountainside Medical or McKesson before deployment in regulated point-of-care settings

• Who Can Purchase: This product is available to licensed healthcare professionals, clinics, hospitals, EMS organisations, institutional buyers, and qualified wholesale purchasers — a medical license or professional credentials may be required at checkout for regulated products
• Pack Size: Sold in boxes of 25 tests — suitable for routine clinical restocking and bulk procurement; contact Mountainside Medical for volume pricing enquiries
• Free Shipping: Free standard US shipping on all orders over $100
• First Order Discount: New customers receive 5% off their first purchase — applied at checkout
• Order Support: For wholesale accounts, volume pricing, or procurement assistance, contact the Mountainside Medical sales team at +1 (888) 687-4334 or sales@mountainside-medical.com
• Returns & Replacements: Return and replacement policy for diagnostic kits — not specified in provided data; contact Mountainside Medical directly for terms applicable to this product

• What is included in the McKesson Rapid Strep A Test Kit?

  Each box contains 25 individually sealed dipsticks, 25 disposable extraction test tubes, 25 sterile throat swabs, Reagent 1 (10 mL; 2M Sodium Nitrite), Reagent 2 (10 mL; 0.2M Acetic Acid), a positive control (1 mL; non-viable Strep A; 0.09% NaN3), a negative control (1 mL; non-viable Strep C; 0.09% NaN3), an instructional insert, and workstations. All components required to complete the testing protocol are included — no additional materials need to be sourced separately.

• How accurate is a rapid strep test kit compared to throat culture?

  Published clinical data indicates rapid strep immunoassay tests typically achieve sensitivity in the range of 70–90% and specificity of 95–99%, compared to throat culture sensitivity of approximately 95% (Choby, Am Fam Physician, 2009). Specificity is high, meaning a positive rapid strep result is highly reliable. Sensitivity is lower, meaning a negative result — particularly in high-suspicion paediatric cases — may warrant confirmatory throat culture. Providers should apply IDSA clinical guidelines when determining whether to confirm a negative rapid result.

• Is this strep test kit CLIA waived?

  CLIA waiver status for this specific McKesson product is not specified in the data currently available on this page. CLIA waiver classification determines whether a test can be performed in non-laboratory point-of-care settings without a laboratory director. We recommend confirming CLIA status directly with Mountainside Medical at +1 (888) 687-4334 or sales@mountainside-medical.com, or by consulting the current McKesson product documentation.

• Can this strep throat test kit be used at home?

  This product is a professional-grade clinical diagnostic kit intended for use by qualified healthcare professionals in point-of-care settings such as clinics, urgent care centres, physicians' offices, and EMS units. It is not labelled or cleared for unsupervised lay consumer use. Individuals seeking a strep test should consult a licensed healthcare provider. Some healthcare professionals do use rapid strep test kits in home visit or telehealth-supported contexts — if you are a healthcare provider enquiring about this use case, contact the Mountainside Medical team for guidance.

• Where can I buy the McKesson Rapid Strep A Test Kit?

  The McKesson strep a test kit is available to purchase directly through Mountainside Medical Equipment at wholesale pricing. Licensed healthcare professionals, clinics, EMS teams, and institutional buyers can place orders online or by contacting the sales team at +1 (888) 687-4334 or sales@mountainside-medical.com. Free shipping is available on US orders over $100, and new customers receive 5% off their first purchase.

• When should a negative rapid strep result be confirmed with throat culture?

  According to IDSA clinical practice guidelines (Shulman et al., Clin Infect Dis, 2012), negative rapid antigen detection test results in children and adolescents with symptoms consistent with streptococcal pharyngitis should be followed by throat culture, due to the higher prevalence of strep in this age group and the meaningful risk of acute rheumatic fever if infection is missed. In adults with low clinical suspicion, a negative rapid strep result is generally sufficient to withhold antibiotics without culture backup. Clinical judgment should always guide this decision.

• What is the difference between Reagent 1 and Reagent 2 in this kit?

  Reagent 1 (2M Sodium Nitrite) and Reagent 2 (0.2M Acetic Acid) work together in a sequential chemical reaction designed to extract the Group A Streptococcal antigen from the throat swab specimen. Reagent 1 initiates the extraction process, and Reagent 2 completes the reaction, producing a processed extract that is applied to the dipstick for antigen detection. Both reagents are chemical solutions and should be handled in accordance with the instructional insert and applicable safety protocols.

• What do the positive and negative controls do in this strep test kit?

  The positive control (non-viable Strep A; 0.09% NaN3) is used to verify that the dipsticks are performing correctly and producing a reactive result when Strep A antigen is present. The negative control (non-viable Strep C; 0.09% NaN3) confirms that the test does not produce false positives through cross-reactivity with non-Strep A antigens. Running both controls is a standard quality assurance practice in point-of-care laboratory testing and is recommended to ensure result reliability, particularly when opening a new kit lot.